Delivery Order SPE2DR25D6029-SPE2DR26FXQ0E
Award Date 11/10/25
Potential Completion Date 11/12/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 28, 2025, for the supply of Abraxane 100 mg vials, a chemotherapy medication used in cancer treatment. The contract is valued at $27,577.40 and carries a firm fixed price structure with an ultimate completion date of October 29, 2025. This is a non-set-aside award issued under competitive procedures, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania....
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Abraxane 100 mg vials valued at $7,565.23. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with a ceiling value of $3,781.37. The contract was competitively awarded without a set-aside designation and is classified as a firm fixed-price delivery order with an ultimate completion date of September 8, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,122.92 firm fixed price delivery order is for 100 mg vials of the cancer drug Abraxane. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,240.98 firm fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the provision of ABRAXANE 100 MG VIALS. The contract has a potential value of $8,837.51 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
- The Defense Logistics Agency awarded a $10,412.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 100 mg vials of ABRAXANE, a chemotherapy medication used to treat breast and lung cancers. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products to DLA and various Department of Defense medical treatment facilities. Amerisourcebergen will fulfill the order from its facility located in Conshohocken,...
- The Defense Logistics Agency awarded a $78,033 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of ABRAXANE, an injectable chemotherapy drug. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 16-17, 2023. No subcontractors or set aside designations were...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $9,044.70, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of August 7, 2024 and is a firm-fixed-price type. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., was awarded this contract without any set-aside...
- This federal contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The $10,010.18 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support...